CRIS Current Research Information System

FIORINI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.030
NA - Nord America 4.116
EU - Europa 3.336
SA - Sud America 302
AF - Africa 139
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.929
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.059
SG - Singapore 1.500
CN - Cina 1.223
VN - Vietnam 1.208
IT - Italia 1.162
GB - Regno Unito 525
HK - Hong Kong 393
DE - Germania 328
SE - Svezia 323
BR - Brasile 234
FR - Francia 211
IN - India 183
RU - Federazione Russa 159
KR - Corea 145
IE - Irlanda 138
NL - Olanda 124
JP - Giappone 85
UA - Ucraina 84
JO - Giordania 75
FI - Finlandia 63
ZA - Sudafrica 63
BG - Bulgaria 40
EE - Estonia 36
ID - Indonesia 32
CA - Canada 30
AR - Argentina 23
AT - Austria 23
PH - Filippine 23
IQ - Iraq 22
TH - Thailandia 21
BD - Bangladesh 20
CI - Costa d'Avorio 20
MX - Messico 20
ES - Italia 19
TR - Turchia 19
CH - Svizzera 18
BE - Belgio 17
TW - Taiwan 17
EC - Ecuador 16
SC - Seychelles 13
PK - Pakistan 12
MY - Malesia 11
PY - Paraguay 10
PL - Polonia 9
GR - Grecia 8
HR - Croazia 8
SA - Arabia Saudita 8
MA - Marocco 7
TN - Tunisia 7
CO - Colombia 6
CZ - Repubblica Ceca 6
EG - Egitto 6
RO - Romania 6
TG - Togo 6
UZ - Uzbekistan 6
AL - Albania 5
AU - Australia 5
LB - Libano 5
RS - Serbia 5
DK - Danimarca 4
KE - Kenya 4
LK - Sri Lanka 4
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
IL - Israele 3
LT - Lituania 3
PE - Perù 3
PT - Portogallo 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
KZ - Kazakistan 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
CD - Congo 1
GH - Ghana 1
GN - Guinea 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
QA - Qatar 1
RE - Reunion 1
SN - Senegal 1
Totale 12.925
Salva come PNG Salva come JPEG
Città #
Singapore 1.019
Southend 455
Ashburn 445
Hong Kong 377
Hefei 328
Chandler 306
Ho Chi Minh City 285
Fairfield 277
Santa Clara 265
San Jose 246
Hanoi 241
Woodbridge 151
Bologna 148
Princeton 144
Dublin 137
Seoul 134
Beijing 132
Wilmington 129
Dong Ket 125
Houston 120
Boardman 118
Seattle 114
Milan 111
Cambridge 104
Ann Arbor 101
Lauterbourg 92
Los Angeles 76
Amman 75
Rome 69
Council Bluffs 64
Tokyo 62
New York 53
Westminster 52
Buffalo 51
Da Nang 49
Helsinki 45
Nanjing 45
Padova 45
Jacksonville 44
Berlin 43
Redmond 40
Sofia 40
Jinan 37
Turin 35
Haiphong 33
São Paulo 32
Tappahannock 31
Bengaluru 30
Redondo Beach 30
Guangzhou 28
Dallas 27
Des Moines 22
Frankfurt am Main 22
Parma 22
Shenyang 22
Biên Hòa 21
Shanghai 21
Abidjan 20
Changsha 20
Naples 19
Nuremberg 18
San Diego 18
Munich 17
Yubileyny 17
Brussels 16
Hebei 16
Jakarta 16
Moscow 16
Saint Petersburg 16
Tianjin 16
Johannesburg 15
Bari 14
Lappeenranta 14
Mülheim 14
Zhengzhou 14
Florence 13
Hangzhou 13
Hải Dương 13
Nanchang 13
Verona 13
Amsterdam 12
Dearborn 12
Shenzhen 12
Bangkok 11
Frattamaggiore 11
London 11
Nakano 11
Rovigo 11
Vienna 11
Can Tho 10
Chicago 10
Montreal 10
Norwalk 10
Bến Tre 9
Mexico City 9
Thái Bình 9
Baghdad 8
Brescia 8
Brooklyn 8
Bühl 8
Totale 7.932
Salva come PNG Salva come JPEG
Nome #
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 565
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 379
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 266
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 220
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 205
Black Garlic and Pomegranate Standardized Extracts for Blood Pressure Improvement: A Non-Randomized Diet-Controlled Study. 188
Gastroesophageal Reflux Disease and Barrett’s Esophagus 188
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 183
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 182
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 177
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 175
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 174
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 169
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 168
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 168
Therapy for H. pylori: Current concepts 166
Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences? 165
Serum uric acid to eGFR ratio correlates with adverse outcomes in elderly hospitalized for acute heart failure 163
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 162
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 160
In vivo dissolution of levothyroxine soft gel capsules 160
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature 160
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 153
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management 151
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 149
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 148
A Systematic Review on Drugs Absorption Modifications after Eradication in Helicobacter pylori Positive Patients undergoing Replacement Therapy 146
Diagnosi dell'infezione da Helicobacter pylori 144
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 143
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 143
Probiotici ricombinanti e loro potenziale sulla salute umana 142
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy 140
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 139
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels 138
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 137
Recombinant probiotics and their potential in human health 137
Cancer Prevention at Work (CPW) project: Rationale, framework and research protocol 136
La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. 136
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 136
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 135
Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. 132
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 132
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 131
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 130
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 129
High eradication rate with sequential therapy in naïve Helicobacter pylori patients with multi-resistant strains 126
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 125
Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori 124
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT 124
Rescue therapies for H. pylori infection in foreign patients treated in Italy. 120
Nephrotic Range Proteinuria and Acute Heart Failure 119
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review 119
Morfologia e modalità di adesione all’epitelio dell’ileo terminale dei batteri filamentosi segmentati. Effetti sulla relazione con il sistema immunitario 118
Diagnostic yield of upper endoscopy according to appropriateness: A systematic review 118
Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019 116
Comparison of the management of Helicobacter pylori infection between the older and younger European populations 115
Pylera and sequential therapy for first-line Helicobacter pylori eradication: A culture-based study in real clinical practice 115
Infezione da Helicobacter pylori e nuovi orientamenti terapeutici: la terapia sequenziale 111
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management 109
Expanding Cancer Prevention: Strategies Integrated into Occupational Health Surveillance 108
More Than 90% Eradication Rate With Sequential Therapy in Clarithromycin Resistant Helicobacter pylori Patients: A Prospective Uncontrolled Study 108
Severe impaired blood pressure control caused by baroreflex failure as a late sequela of neck irradiation 107
Effectiveness of high-dose esomeprazole or pantoprazole 10-day sequential therapy empirically prescribed in Helicobacter pylori-infected naïve patients: a retrospective study 106
Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale 103
Role of Helicobacter Pylori Infection in the Thyroid Diseases 103
Upper Endoscopy in Patients with Extra-Oesophageal Reflux Symptoms: A Multicentre Study 103
European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients 101
The role of the occupational physician in controlling gastric cancer attributable to Helicobacter pylori infection: A review 100
Efficacy of a new nutraceutical formulation (CHETOGERD®) in patients with nonerosive reflux (NERD): a prospective observational study. 99
Efficacy and Safety of Low-Dose Bisoprolol/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Systematic Review and Meta-Analysis 98
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 98
Sequential therapy for first-line helicobacter pylori eradication: 10- or 14-day regimen? 97
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection 95
Whipple’s Disease: Case Report and Review of the Literature 94
Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia. 92
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 90
Newer agents for Helicobacter pylori eradication 87
Helicobacter pylori: la nuova terapia. 86
Paradigm shift: The copernican revolution in diverticular disease 85
null 83
Rescue Therapies for H. pylori Infection in Italy 82
null 81
Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy 81
Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review 81
Gestione del paziente, diagnostica rapida, nuove terapie per l’infezione da Helicobacter pylori. 77
Lung ultrasound in the COVID-19 era: a lesson to be learned for the future 76
Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data? 76
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 74
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 74
Effect of dietary supplementation with Diuripres® on blood pressure, vascular health, and metabolic parameters in individuals with high-normal blood pressure or stage I hypertension: The CONDOR randomized clinical study 74
Diverticulosis, Adenomas, and Cancer in the Colon A Systematic Review and Meta-Analysis of Endoscopic Studies 73
Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains 73
Helicobacter Pylori infection in psoriatic patients during biological therapy 69
Comparative Evaluation of Tongue and Periodontal Pocket Microbiome in Relation to Helicobacter pylori Gastric Disease: 16S rRNA Gene Sequencing Analysis 69
Is the First Cut Always the Deepest? 68
Renin-angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study 66
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 63
null 62
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 60
New strategies for the treatment of hyperkalemia. 58
Totale 12.889
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021289 0 0 0 0 0 0 0 0 0 37 29 223
2021/20221.194 114 40 58 123 125 44 27 86 42 31 333 171
2022/20231.375 118 140 89 160 77 110 55 92 314 70 93 57
2023/2024719 45 123 49 83 39 96 39 40 23 65 66 51
2024/20252.432 107 356 194 169 392 145 161 95 50 102 143 518
2025/20265.109 413 513 461 432 585 358 696 232 1.059 360 0 0
Totale 13.173